Norden Group LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,024 shares of the healthcare conglomerate's stock after selling 979 shares during the period. Norden Group LLC's holdings in UnitedHealth Group were worth $3,156,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Financial Management Professionals Inc. lifted its stake in shares of UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after purchasing an additional 17 shares during the period. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 28.6% in the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after buying an additional 20 shares during the period. Kolinsky Wealth Management LLC increased its stake in UnitedHealth Group by 1.0% in the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after purchasing an additional 21 shares in the last quarter. Retirement Planning Group LLC boosted its position in shares of UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after purchasing an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group increased its position in shares of UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after buying an additional 21 shares in the last quarter. 87.86% of the stock is owned by institutional investors.
Insider Activity
In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the company's stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director directly owned 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The stock was bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director owned 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by insiders.
UnitedHealth Group Price Performance
NYSE:UNH opened at $280.69 on Monday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a fifty day simple moving average of $301.58 and a 200 day simple moving average of $424.22. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a market capitalization of $254.62 billion, a PE ratio of 11.75, a P/E/G ratio of 1.39 and a beta of 0.45.
UnitedHealth Group Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 3.15%. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.
Analyst Ratings Changes
A number of research firms have issued reports on UNH. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a report on Tuesday, June 3rd. Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Finally, Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $351.00 to $306.00 and set an "overweight" rating for the company in a research note on Friday. One analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $392.29.
Check Out Our Latest Research Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.